Skip to main content
SpringerLink
Log in

Behçet's Disease

  • Chapter
Uveitis and Immunological Disorders

Part of the book series: Essentials in Ophthalmology ((ESSENTIALS))

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Adamantiades B (1931) Sur un cas d'iritis á hypopyon recidivante. Ann Ocul (Paris) 168:271–274

    Google Scholar 

  2. Adler YD, Mansmann U, Zouboulis CC (2001) Mycophenolate mofetil is ineffective in the treatment of mucocutaneous Adamantiades-Behçet's disease. Dermatology 203:322–324

    Article  PubMed  Google Scholar 

  3. Ahmad T, Wallace GR, James TE, et al. (2003) Mapping the HLA association in Behcet's disease: a role for tumor necrosis factor polymorphisms? Arthritis Rheum 48:807–813

    Article  PubMed  Google Scholar 

  4. Akman-Demir G, Serdaroglu P, Tasci B (1999) Clinical patterns of neurological involvement in Behcet's disease: evaluation of 200 patients. The Neuro-Behcet Study Group. Brain 122:2171–2182

    Article  PubMed  Google Scholar 

  5. Atmaca LS (1989) Fundus changes associated with Behçet's disease. Arch Clin Exp Ophthalmol 227:340–344

    Article  Google Scholar 

  6. Atmaca LS, Batioglu F, Ýdil A (1996) Retinal and disc neovascularisation in Behçet's disease and efficacy of laser photocoagulation. Graefes Arch Clin Exp Ophthalmol 234:94–99

    Article  PubMed  Google Scholar 

  7. Aydintug O, Tokgöz G, D'Cruz DP, Gürler A, Cervera R, Düzgün N, et al. (1993) Antibodies to endothelial cells in patients with Behçet's disease. Clin Immunol Immunopathol 67:157–162

    PubMed  Google Scholar 

  8. Bang D (1997) Treatment of Behçet's disease. Yonsei Med J 38:401–410

    PubMed  Google Scholar 

  9. Behçet H (1937) Über rezidivierende aphtöse, durch ein Virus verursachte Geschwüre am Mund, am Auge und an den Genitalien. Derm Wochenschr 36:1152–1157

    Google Scholar 

  10. Ben-Chetrit E, Cohen R, Chajek-Shaul T (2002) Familial Mediterranean fever and Behcet's disease — are they associated? J Rheumatol 29:530–534

    PubMed  Google Scholar 

  11. BenEzra D, Cohen E (1986) Treatment and visual prognosis in Behçet's disease. Br J Ophthalmol 70:589–592

    PubMed  Google Scholar 

  12. Bentley CR, Stanford MR, Shilling JS (1993) Macular ischemia in posterior uveitis. Eye 7:411–414

    PubMed  Google Scholar 

  13. Boiardi L, Salvarani C, Casali B, et al. (2001) Intercellular adhesion molecule-1 gene polymorphisms in Behcet's disease. J Rheumatol 28:1283–1287

    PubMed  Google Scholar 

  14. Carletto A, Pacor ML, Biasi D, Caramaschi P, Zemininan S, Bellavite P, et al. (1997) Changes of neutrophil migration without modification of in vitro metabolism and adhesion in Behçet's disease. J Rheumatol 24:1332–1336

    PubMed  Google Scholar 

  15. Chafa O, Fischer AM, Meriane F, Chellali T, Sternberg C, Otmani F, et al. (1992) Behçet syndrome associated with protein S deficiency. Thromb Haemostasis 67:1–3

    Google Scholar 

  16. Chajek T, Fainaru M (1975) Behçet's disease: report of 41 cases and a review of the literature. Medicine 54:179–196

    PubMed  Google Scholar 

  17. Chajek-Shaul T, Pisanty S, Knobler H, et al. (1987) HLA-B*51 may serve as an immunogenetic marker for a subgroup of patients with Behcet's syndrome. Am J Med 83:666–672

    PubMed  Google Scholar 

  18. Chambers JC, Haskard DO, Kooner JS (2001) Vascular endothelial function and oxidative stress mechanisms in patients with Behçet's syndrome. J Am Coll Cardiol 37:517–520

    Article  PubMed  Google Scholar 

  19. Choukri F, Chakib A, Himmich H, Hue S, Caillat-Zucman S (2001) HLA-B*51 and B*15 alleles confer predisposition to Behcet's disease in Moroccan patients. Hum Immunol 62:180–185

    Article  PubMed  Google Scholar 

  20. Chung YM, Yeh TS, Sheu MM (1990) Behcet's disease with ocular involvement in Taiwan: a joint survey of six major ophthalmological departments. J Formos Med Assoc 89:413–417

    PubMed  Google Scholar 

  21. Cochereau-Massin I, Wechsler B, Le Hoang P, et al. (1992) Prognostic oculaire de la maledie de Behçet. J Fr Ophthalmol 15:343–347

    Google Scholar 

  22. Criteria for Diagnosis of Behcet's Disease (1990) International Study Group for Behcet's Disease. Lancet 335:1078–1080

    Google Scholar 

  23. Davatchi F, Shahram F, Akkbarian M (1992) The prevalence of Behçet's disease in Iran. In: Nasution AR, Darmawan J, Isbagio H (eds) Proceedings of the 7th APLAR Congress of Rheumatology. Churchill Livingstone, Japan, pp 95–98

    Google Scholar 

  24. deSmet MD, Dayan M (2000) Prospective determination of T-cell responses to S-antigen in Behçet's disease patients and controls. Invest Ophthamol Vis Sci 41:3480–3484

    Google Scholar 

  25. Deuter CME, Kötter I, Günaydin I, Zierhut M, Stübiger N (2004) Ocular involvement in Behçet's disease: first 5-year results for visual development after treatment with interferon alfa-2a. Ophthalmologe 101:129–134

    Article  PubMed  Google Scholar 

  26. Dilsen N, Konice M, Aral O (1985) Our diagnostic criteria of Behcet's disease — an overview: recent advances in Behcet's disease. Royal Society of Medicine Services, London

    Google Scholar 

  27. Dilsen N, Konice M, Aral O, Ocal L, Inanc M, Gul A (1993) Comparative study of the skin pathergy test with blunt and sharp needles in Behcet's disease: confirmed specificity but decreased sensitivity with sharp needles. Ann Rheum Dis 52:823–825

    PubMed  Google Scholar 

  28. Dilsen N (1996) History and development of Behçet's disease. VII International Conference on Behçet's Disease. Rev Rheum Engl Ed 63:512–519

    Google Scholar 

  29. Dundar SV, Gencalp U, Simsek H (1985) Familial cases of Behçet's disease. Br J Dermatol 113:319–321

    PubMed  Google Scholar 

  30. Efthimiou J, Addison IE, Johnson BV (1989) In vivo leukocyte migration in Behçet's syndrome. Ann Rheum Dis 48:206–210

    PubMed  Google Scholar 

  31. Eglin RP, Lehner T, Subak-Sharpe JH (1982) Detection of RNA complementary to herpes simplex virus in mononuclear cells from patients with Behçet's syndrome and recurrent oral ulcers. Lancet 2:1356–1361

    Article  PubMed  Google Scholar 

  32. Eksioglu-Demiralp E, Direskeneli H, Ergun T, Fresko I, Akoglu T (1999) Increased CD4+CD16+ and CD4+CD56+T cell subsets in Behçet's disease. Rheumatol Int 19:23–26

    Article  PubMed  Google Scholar 

  33. Er H, Evereklioglu C, Cumureu T, Turkoz Y, Ozerol E, Sahin K, et al. (2002) Serum homocysteine level is increased and correlated with endothelin-1 and nitric oxide in Behçet's disease. Br J Ophthalmol 86:653–567

    Article  PubMed  Google Scholar 

  34. Esin S, Gul A, Hodara V, Jeddi-Tehrani M, Dilsen N, Konice M, et al. (1997) Peripheral blood T cell expansions in patients with Behcet's disease. Clin Exp Immunol 107:520–527

    Article  PubMed  Google Scholar 

  35. Espinosa G, Font J, Tassies D, et al. (2002) Vascular involvement in Behcet's disease: relation with thrombophilic factors, coagulation activation, and thrombomodulin. Am J Med 112:37–43

    Article  PubMed  Google Scholar 

  36. Estrach C, Mpofu S, Moots RJ (2002) Behçet's syndrome: response to infliximab after failure of etanercept. Rheumatology 41:1213–1214

    Article  Google Scholar 

  37. Evereklioglu C, Turkoz Y, Er H, Inaloz HS, Ozbek E, Cekmen M (2002) Increased nitric oxide production in patients with Behçet's disease: is it a new activity marker? J Am Acad Dermatol 46:50–54

    Article  PubMed  Google Scholar 

  38. Falk K, Rotzschke O, Takiguchi M, et al. (1995) Peptide motifs of HLA-B*51,-B52 and-B78 molecules, and implications for Behcet's disease. Int Immunol 7:223–228

    PubMed  Google Scholar 

  39. Fortune F, Walker J, Lehner T (1990) The expression of γδT cell receptor and the prevalence of primed, activated and Ig-A bound T cell in Behçet's syndrome. Clin Exp Immunol 82:326–332

    PubMed  Google Scholar 

  40. Freydottir J, Lau SH, Fortune F (1999) γδT cells in Behçet's disease (BD) and recurrent aphthous stomatitis (RAS). Clin Exp Immunol 118:451–457

    Article  PubMed  Google Scholar 

  41. Gonzalez-Escribano MF, Rodriguez MR, Walter K, Sanchez-Roman J, Garcia-Lozano JR, Nunez-Roldan A (1998) Association of HLA-B*51 subtypes and Behcet's disease in Spain. Tissue Antigens 52:78–80

    PubMed  Google Scholar 

  42. Gül A, Esin S, Dilsen N, Konice M, Wigzell H, Biberfeld P (1995) Immunohistology of skin pathergy reaction in Behcet's disease. Br J Dermatol 132:901–907

    PubMed  Google Scholar 

  43. Gül A, Özbek U, Öztürk C, Inanç M, Koniçe M, Özçelik T (1996) Coagulation factor V gene mutation increases the risk of venous thrombosis in Behçet's disease. Br J Rheumatol 35:1178–1180

    Article  PubMed  Google Scholar 

  44. Gül A, Aslantas AB, Tekinay T, Koniçe M, Özçelik T (1999) Procoagulant mutations and venous thrombosis in Behçet's disease. Rheumatology (Oxford) 38:1298–1299

    Article  PubMed  Google Scholar 

  45. Gül A, Inanc M, Ocal L, Aral O, Konice M (2000) Familial aggregation of Behcet's disease in Turkey. Ann Rheum Dis 59:622–625

    Article  PubMed  Google Scholar 

  46. Gül A, Hajeer AH, Worthington J, Ollier WE, Silman AJ (2001) Linkage mapping of a novel susceptibility locus for Behcet's disease to chromosome 6p22–23. Arthritis Rheum 44:2693–2696

    Article  PubMed  Google Scholar 

  47. Gül A, Uyar FA, Inanc M, et al. (2001) Lack of association of HLA-B*51 with a severe disease course in Behcet's disease. Rheumatology (Oxford) 40:668–672

    Article  PubMed  Google Scholar 

  48. Gürler A, Boyvat A, Türsen Ü (1997) Clinical manifestations of Behcet's disease: an analysis of 2147 patients. Yonsei Med J 38:423–427

    PubMed  Google Scholar 

  49. Hamuryudan V, Özyazgan Y, Hizli N, Mat C, Yurdakul S, Tüzün Y, aenocak M, Yazici H (1997) Azathioprine in Behçet's syndrome: effects on long-term prognosis. Arthritis Rheum 40:769–774

    PubMed  Google Scholar 

  50. Hamuryudan V, Mat C, Saip S, Ozyazgan Y, Siva A, Yurdakul S, Zwingenberger K, Yazici H (1998) Thalidomide in the treatment of the mucocutaneous lesions of the Behçet syndrome. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 128:443–450

    PubMed  Google Scholar 

  51. Hamzaoui K, Ayed K, Hamza M, et al. (1988) Natural killer cells in Behcet's disease. Clin Exp Immunol 71:126–131

    PubMed  Google Scholar 

  52. Hasan A, Fortune F, Wilson A, Warr K, Shinnick T, Mizushima Y, et al. (1996) Role of γδT cells in pathogenesis and diagnosis of Behçet's disease. Lancet 347:789–794

    Article  PubMed  Google Scholar 

  53. Hirohata S, Hashimoto S (1998) Abnormal T cell responses to bacterial superantigens in Behçet's disease. Clin Exp Immunol 112:317–324

    Article  PubMed  Google Scholar 

  54. Houman MH, Ben Ghorbel I, Khiari Ben Salah I, Lamloum M, Ben Ahmed M, Miled M (2001) Deep vein thrombosis in Behcet's disease. Clin Exp Rheumatol 19:S48–50

    PubMed  Google Scholar 

  55. Hu W, Hasa A, Wilson A, Stanford MR, Li-Yang Y, Todryk S, et al. (1998) Experimental mucosal induction of uveitis with 60-kDa heat shock protein-derived peptide 336–351. Eur J Immunol 28:2444–2455

    PubMed  Google Scholar 

  56. Ishihara M, Ohno S, Mizuki N, et al. (1996) Allelic variations in the TAP2 and LMP2 genes in Behcet's disease. Tissue Antigens 47:249–252

    PubMed  Google Scholar 

  57. Isogyi E, Ohno S, Kotake S, Isogai H, Tsurumizu T, Fujii N, et al. (1990) Chemiluminescence of neutrophils from patients with Behçet's disease and its correlation with an increased proportion of uncommon serotypes of Streptococcus sanguis in the oral flora. Arch Oral Biol 35:43–48

    Article  PubMed  Google Scholar 

  58. Joseph A, Raj D, Dua HS, Powell PT, Lanyon PC, Powell RJ (2003) Infliximab in the treatment of refractory posterior uveitis. Ophthalmology 110:1449–1453

    PubMed  Google Scholar 

  59. Kadayifcilar S, Gedik S, Eldem B, Irkec M (2002) Cataract surgery in patients with Behçet's disease. J Cataract Refract Surg 28:316–320

    Article  PubMed  Google Scholar 

  60. Kahan A, Hamzaoui K, Ayed K (1992) Abnormalities of T lymphocyte subsets in Behçet's disease demonstrated with anti-CD45RA and anti-CD29 monoclonal antibodies. J Rheumatol 19:742–746

    PubMed  Google Scholar 

  61. Kaklamani VG, Kaklamanis PG (2001) Treatment of Behçet's disease — an update. Semin Arthritis Rheum 30:299–312

    PubMed  Google Scholar 

  62. Kaktos (1993) In:Hippokrates (ed) Third book on epidemiology. Case 7,13:209

    Google Scholar 

  63. Kaneko F, Takahashi Y, Muramatsu R, Adachi K, Miura Y, Nakane A (1985) Natural killer cell numbers and function in peripheral lymphoid cells in Behçet's disease. Br J Dermatol 113:313–318

    PubMed  Google Scholar 

  64. Kaneko S, Suzuki N, Yamashita N, Nagafuchi H, Nakajima T, Wakisaka S, et al. (1997) Characterization of T cells specific for an epitope of human 60-kD heat shock protein (hsp) in patients with Behçet's disease (BD) in Japan. Clin Exp Immunol 108:204–212

    Article  PubMed  Google Scholar 

  65. Karasneh J, Hajeer AH, Barrett J, Ollier WER, Thornhill M, Gul A (2003) Association of specific interleukin 1 gene cluster polymorphisms with increased susceptibility for Behcet's disease. Rheumatology 42:860–864

    Article  PubMed  Google Scholar 

  66. Kato Y, Numaga J, Kato S, Kaburaki T, Kawashima H, Fujino Y (2001) Central nervous system symptoms in a population of Behçet's disease patients with refractory uveitis treated with cyclosporine A. Clin Exp Ophthalmol 29:335–336

    Article  Google Scholar 

  67. Keino H, Sakai JI, Nishioka K, Sumida T, Usui M (2000) Clonally accumulating T cells in the anterior chamber of Behçet's disease. Am J Ophthalmol 130:243–245

    Article  PubMed  Google Scholar 

  68. Kilmartin DJ, Finch A, Acheson RW (1997) Primary association of HLA-B*51 with Behcet's disease in Ireland. Br J Ophthalmol 81:649–653

    PubMed  Google Scholar 

  69. Kilmartin DJ, Forrester JV, Dick AD (1998) Tacrolimus (FK506) in failed cyclosporine A therapy in endogenous posterior uveitis. Ocul Immunol Inflamm 6:101–109

    Article  PubMed  Google Scholar 

  70. Kiraz S, Ertenli I, Çalgüneri M, Öztürk MA, Haznedaroglu IC, Altun B, et al. (2001) Interactions of nitric oxide and superoxide dismutase in Behçet's disease. Clin Exp Rheumatol 19(Suppl 24):S25–S29

    Google Scholar 

  71. Kitaichi N, Kotake S, Sasamoto Y, Namba K, Matsuda A, Ogasawara K, et al. (1999) Prominent increase of macrophage migration inhibitory factor in the sera of patients with uveitis. Invest Ophthalmol Vis Sci 40:247–250

    PubMed  Google Scholar 

  72. Kitaichi N, Ogasawara K, Iwabuchi K, Nishihira J, Namba K, Onoé K Jr, et al. (1999) Different influence of macrophage migration inhibitory factor (MIF) in signal transduction pathway of various T cell subsets. Immunobiology 201:356–367

    Google Scholar 

  73. Kotake S, Higashi K, Yoshikawa K, Sasamoto Y, Okamoto T, Matsuda H (1999) Central nervous system symptoms in patients with Behçet disease receiving cyclosporine therapy. Ophthalmology 106:586–589

    Article  PubMed  Google Scholar 

  74. Kötter I, Stübiger N (1999) Aktuelle Aspekte der Diagnostik und Therapie des Morbus Behçet. Akt Rheumatol 24:51–57

    Google Scholar 

  75. Kötter I, Gunaydin I, Stubiger N, et al. (2001) Comparative analysis of the association of HLA-B*51 suballeles with Behcet's disease in patients of German and Turkish origin. Tissue Antigens 58:166–170

    Article  PubMed  Google Scholar 

  76. Kötter I, Stübiger N, Zierhut M (2003) Use of interferon-α in Behçet's disease. In: Zierhut M, Ohno S (eds) Immunology of Behçet's disease. Swets & Zeitlinger, Lisse, Netherlands, pp 155–159

    Google Scholar 

  77. Kötter I, Zierhut M, Eckstein AK, Vonthein R, Ness T, Guenaydin I, Grimbacher B, Blaschke S, Meyer-Riemann W, Peter HH, Stübiger N (2003) Human recombinant interferon alfa-2a for the treatment of Behçet's disease with sight threatening posterior or panuveitis. Br J Ophthalmol 87:423–431

    Article  PubMed  Google Scholar 

  78. Krause I, Uziel Y, Guedj D et al. (1998) Mode of presentation and multisystem involvement in Behcet's disease: the influence of sex and age of disease onset. J Rheumatol 25:1566–1569

    PubMed  Google Scholar 

  79. Krause L, Turnbull JR, Torun N, Pleyer U, Zouboulis CC, Förster MH (2003) Interferon alfa-2a in the treatment of ocular Adamantiades-Behçet's disease. Adv Exp Med Biol 528:511–519

    PubMed  Google Scholar 

  80. Kretschmann K, Seeliger MW, Ruether K, et al. (1998) Multifocal electroretinography in patients with macular dystrophy. Br J Ophthalmol 82:267–275

    Article  PubMed  Google Scholar 

  81. Lee CR, Kim WH, Cho YS, et al. (2001) Colono-scopic findings in intestinal Behcet's disease. Inflamm Bowel Dis 7:243–249

    Article  PubMed  Google Scholar 

  82. Lee KH, Bang D, Choi ES, Chun WH, Lee ES, Lee S (1999) Presence of circulating antibodies to a disease-specific antigen on cultured human dermal microvascular endothelial cells in patients with Behçet's disease. Arch Dermatol Res 291:374–381

    Article  PubMed  Google Scholar 

  83. Lee S (1997) Diagnostic criteria of Behcet's disease: problems and suggestions. Yonsei Med J 38:365–369

    PubMed  Google Scholar 

  84. Lehner T, Lavery E, Smith R, von der Zee R, Mizushima Y, Shinnick T (1991) Association between the 65-kilodalton heat shock protein, Streptococcus sanguis, and the corresponding antibodies in Behçet's disease. Infect Immun 59:1434–1441

    PubMed  Google Scholar 

  85. Lehner T (1997) The role of heat shock protein, microbial and autoimmune agents in aetiology of Behçet's disease. Intern Rev Immunol 14:21–32

    Google Scholar 

  86. Lehner T (2000) Immunopathogenesis of Behçet's disease. In: Bang D, Lee ES, Lee S (eds) Behçet's disease. Design Mecca, Seoul, pp 3–18

    Google Scholar 

  87. Leiba M, Sidi Y, Gur H, Leiba A, Ehrenfeld M (2001) Behcet's disease and thrombophilia. Ann Rheum Dis 60:1081–1085

    Article  PubMed  Google Scholar 

  88. Livneh A, Aksentijevich I, Langevitz P, et al. (2001) A single mutated MEFV allele in Israeli patients suffering from familial Mediterranean fever and Behcet's disease (FMF-BD). Eur J Hum Genet 9:191–196

    Article  PubMed  Google Scholar 

  89. Mammo L, Al-Dalaan A, Bahabri SS, Saour JN (1997) Association of factor V Leiden with Behçet's disease. J Rheumatol 24:2196–2198

    PubMed  Google Scholar 

  90. Mamo JG (1970) The rate of visual loss in Behçet's disease. Arch Ophthalmol 84:451–452

    PubMed  Google Scholar 

  91. Mason RM, Barnes CG (1969) Behcet's syndrome with arthritis. Ann Rheum Dis 28:95–103

    Google Scholar 

  92. Matsuo T, Sato Y, Shiraga F, et al. (1999) Choroidal abnormalities in Behçet's disease observed by simultaneous indocyanine green and fluorescein angiography with scanning laser ophthalmoscopy. Ophthalmology 106:295–300

    Article  PubMed  Google Scholar 

  93. McLennan N, Masters M (1998) GroE is vital for cell-wall synthesis. Nature 392:1–39

    Article  Google Scholar 

  94. Mege JL, Dilsen N, Sanguedolce V, Gul A, Bongrand P, Roux H, et al. (1993) Overproduction of monocyte derived tumor necrosis factor α, interleukin (IL) 6, IL-8 and increased neutrophil superoxide generation in Behçet's disease. A comparative study with familial Mediterranean fever and healthy subjects. J Rheumatol 20:1544–1549

    PubMed  Google Scholar 

  95. Misgav M, Goldberg Y, Zeltser D, Eldor A, Berliner AS (2000) Fatal pulmonary artery thrombosis in a patient with Behçet's disease, activated protein C resistance and hyper-homocysteinemia. Blood Coagul Fibrinolysis 11:421–423

    Article  PubMed  Google Scholar 

  96. Mishima S, Masuda K, Izawa Y, et al. (1979) Behçet's disease in Japan: Ophthalmological aspects. Trans Am Ophthalmol Soc 76:225–279

    Google Scholar 

  97. Mizuki N, Ohno S, Ando H, et al. (1996) HLA-C genotyping of patients with Behcet's disease in the Japanese population. Hum Immunol 50:47–53

    Article  PubMed  Google Scholar 

  98. Mizuki N, Inoko H, Ohno S (1997) Molecular genetics (HLA) of Behcet's disease. Yonsei Med J 38:333–349

    PubMed  Google Scholar 

  99. Mizuki N, Ota M, Yabuki K, et al. (2000) Localization of the pathogenic gene of Behcet's disease by microsatellite analysis of three different populations. Invest Ophthalmol Vis Sci 41:3702–3708

    PubMed  Google Scholar 

  100. Mizushima Y (1988) Revised diagnostic criteria for Behcet's disease in 1987. Ryumachi 28:66–70

    PubMed  Google Scholar 

  101. Mochizuki M, Suzuki N, Takeno M, Nagafuchi H, Harada T, Kaneoka H, et al. (1994) Fine antigen specificity of human γδT cell lines Vγ9+ established by repetitive stimulation with a serotype (KTH-1) of a gram-positive bacterium, Streptococcus sanguis. Eur J Immunol 24:1536–1543

    PubMed  Google Scholar 

  102. Mochizuki M (1997) Immunotherapy for Behçet's disease. Intern Rev Immunol 14:49–66

    Google Scholar 

  103. Müftüoglu AÜ, Yazici H, Yurdakul S, et al. (1981) Behçet's disease: lack of correlation of clinical manifestations with HLA antigens. Tissue Antigens 17:226–230

    PubMed  Google Scholar 

  104. Nakae K, Masaki F, Hashimoto T, et al. (1993) Behçet's disease. In:Wechsler B, Godeau P (eds) International Congress Series 1037. Excerpta Medica, Amsterdam, pp 145–151

    Google Scholar 

  105. Nakamura S, Ohno S (2003) The efficacy of anti-TNF-alpha antibody in the treatment of uveitis patients with Behçet's disease. In: Zierhut M, Ohno S (eds) Immunology of Behçet's disease. Swets & Zeitlinger, Lisse, Netherlands, pp 151–154

    Google Scholar 

  106. Niwa Y, Miyake S, Sakane T, Shingu M, Yokoyama M (1982) Auto-oxidative damage in Behçet's disease — endothelial cell damage following the elevated oxygen radicals generated by stimulated neutrophils. Clin Exp Immunol 49:247–255

    PubMed  Google Scholar 

  107. Niwa Y, Mizushima Y (1990) Neutrophil-potentiating factors released from stimulated lymphocytes; special reference to the increase in neutrophil-potentiating factors from streptococcus-stimulated lymphocytes of patients with Behçet's disease. Clin Exp Immunol 79:353–360

    PubMed  Google Scholar 

  108. Nussenblatt RB, Palestine AG, Chan CC, Mochizuki M, Yancey K (1985) Effectiveness of cyclosporine therapy for Behçet's disease. Arthritis Rheum 28:671–679

    PubMed  Google Scholar 

  109. O'Duffy JD (1974) Suggested criteria for diagnosis of Behçet's disease. J Rheumatol 1:18

    Google Scholar 

  110. O'Duffy JD, Robertson DM, Goldstein NP (1984) Chlorambucil in the treatment of uveitis and meningoencephalitis of Behçet's disease. Am J Med 76:75–84

    Article  PubMed  Google Scholar 

  111. Ohno S, Ohguchi M, Hirose S, et al. (1982) Close association of HLA-Bw51 with Behcet's disease. Arch Ophthalmol 100:1455–1458

    PubMed  Google Scholar 

  112. Orem A, Vanizor B, Cimsit, Kiran E, Deger O, Malkoc M (1999) Decreased nitric oxide production in patients with Behçet's disease. Dermatology 198:33–36

    Article  PubMed  Google Scholar 

  113. Özdal PÇ, Ortaç S, Taskintuna I, Firat E (2002) Long-term therapy with low dose cyclosporine A in ocular Behçet's disease. Doc Ophthalmol 105:301–312

    Article  PubMed  Google Scholar 

  114. Palimeris G, Papakonstantinou P, Mantas M (1984) The Adamantiades-Behçet's syndrome in Greece. In: Saari KM (ed) Uveitis update. Excerpta Medica, Amsterdam, p 321

    Google Scholar 

  115. Park KD, Bang D, Lee ES, Lee SH, Lee S (1993) Clinical study on death in Behcet's disease. J Korean Med Sci 8:241–245

    PubMed  Google Scholar 

  116. Park SH, Park KS, Seo YI, et al. (2002) Association of MICA polymorphism with HLA-B*51 and disease severity in Korean patients with Behcet's disease. J Korean Med Sci 17:366–370

    PubMed  Google Scholar 

  117. Paul M, Klein T, Krause I, Molad Y, Narinsky R, Weinberger A (2001) Allelic distribution of HLA-B* 5 in HLA-B5-positive Israeli patients with Behcet's disease. Tissue Antigens 58:185–186

    Article  PubMed  Google Scholar 

  118. Pronai L, Ichikawa Y, Nakzawa H, Arimori S (1991) Enhanced superoxide generation and the decreased scavenging activity of peripheral blood leukocytes in Behçet's disease — effect of colchicines. Clin Exp Rheumatol 9:227–233

    PubMed  Google Scholar 

  119. Rammensee HG, Friede T, Stevanovic S (1995) MHC ligands and peptide motifs: first listing. Immunogenetics 41:178–228

    Article  PubMed  Google Scholar 

  120. Robinson J, Waller MJ, Parham P, Bodmer JG, Marsh SG (2001) IMGT/HLA database — a sequence database for the human major histocompatibility complex. Nucleic Acids Res 29:210–213

    Article  PubMed  Google Scholar 

  121. Sahin S, Akoglu T, Direskeneli H, Sen LS, Lawrence R (1996) Neutrophil adhesion to endothelial cells and factors affecting adhesion in patients with Behçet's disease. Ann Rheum Dis 55:128–133

    PubMed  Google Scholar 

  122. Sakane T, Kotani H, Takada S, Tsunematsu T (1982) Functional aberration of T cell subsets in patients with Behçet's disease. Arthritis Rheum 25:1343–1351

    PubMed  Google Scholar 

  123. Sakane T, Takeno M, Suzuki N, Inaba G (1999) Behcet's disease. N Engl J Med 341:1284–1291

    Article  PubMed  Google Scholar 

  124. Salavarani C, Calamia K, Silingardi M, Ghirarduzzi A, Olivieri I (2000) Thrombosis associated with the prothrombin GA20210 mutation in Behçet's disease. J Rheumatol 27:515–516

    PubMed  Google Scholar 

  125. Salvarani C, Boiardi L, Casali B, Olivieri I, Ciancio G, Cantini F, et al. (2002) Endothelial nitric oxide synthase gene polymorphisms in Behçet's disease. J Rheumatol 29:535–540

    PubMed  Google Scholar 

  126. Saylan T, Özarmargan G, Azizlerli G, et al. (1986) Behçet disease in Turkey. N Zbl Hautkr 1120–1122

    Google Scholar 

  127. Serdaroglu P (1998) Behcet's disease and the nervous system. J Neurol 245:197–205

    Article  PubMed  Google Scholar 

  128. Sfikakis PP, Theodossiadis PG, Katsiari CG, Kaklamanis P, Markomichelakis NN (2001) Effect of infliximab on sight-threatening panuveitis in Behçet's disease. Lancet 358:295–296

    Article  PubMed  Google Scholar 

  129. Shehto NM, Ghosh K, Abdul Kader B, al Assad HS (1992) Extensive venous thrombosis in a case of Behçet's disease associated with heterozygous protein C deficiency. Thromb Haemostasis 67:283

    Google Scholar 

  130. Shimizu T, Matsumura N (1972) [Behcet's disease]. Nippon Rinsho 30:416–420

    PubMed  Google Scholar 

  131. Sloper CML, Powell RJ, Dua HS (1999) Tacrolimus (FK506) in the treatment of posterior uveitis refractory to cyclosporine. Ophthalmology 106:723–728

    Article  PubMed  Google Scholar 

  132. Stratigos AJ, Laskaris G, Stratigos JD (1992) Behçet's disease. Semin Neurol 12:346–357

    PubMed  Google Scholar 

  133. Stübiger N, Besch D, Deuter CME, et al. (2003) Multifocal ERG changes in patients with ocular Behçet's disease during therapy with interferon alpha 2a. In: Zouboulis CC (ed) Adamantiades-Behçet's disease (Proceedings of the 10th International Conference on Behçet's disease, Berlin), vol 528. Kluwer Academic/Plenum Publishers, New York, pp 529–532

    Google Scholar 

  134. Stübiger N, Kötter I, Zierhut M (2000) Complete regression of retinal neovascularisation after therapy with interferon alfa in Behçet's disease. Br J Ophthalmol 84:1437–1438

    Google Scholar 

  135. Stübiger N, Zierhut M, Kötter I (2003) Ocular manifestations in Behçet's disease. In: Zierhut M, Ohno S (eds) Immunology of Behçet's disease. Swets & Zeitlinger, Lisse, Netherlands, pp 36–45

    Google Scholar 

  136. Süllü Y, Öge I, Erkan D, Aritürk N, Mohajeri F (1998) Cyclosporin-A therapy in severe uveitis of Behçet's disease. Acta Ophthalmol Scand 76:96–99

    Article  PubMed  Google Scholar 

  137. Sumita K, Yamashita N, Takeno M, Sakane T (1997) Dysregulated tyrosine phosphorylation cascade in TCR/CD3 signaling pathway leads to T cell irritability in patients with Behçet's disease. Arthritis Rheum 40(Suppl):S232

    Google Scholar 

  138. Suzuki Y, Hoshi K, Matsuda T, Mizushima Y (1992) Increased peripheral blood gδ T cells and natural killer cells in Behçet's disease. J Rheumatol 19:588–592

    PubMed  Google Scholar 

  139. Tokay S, Direskeneli H, Yurdakul S, Akoglu T (2001) Anticardiolipin antibodies in Behçet's disease: a reassessment. Rheumatology (Oxford) 40:192–195

    Article  PubMed  Google Scholar 

  140. Toker E, Kazokoglu H, Acar N (2002) High dose intravenous steroid therapy for severe posterior segment uveitis in Behçet's disease. Br J Ophthalmol 86:521–523

    Article  PubMed  Google Scholar 

  141. Triolo G, Accardo-Palumbo A, Triolo G, Carbone MC, Ferrante A, Giardina E (1999) Enhancement of endothelial cell E-selection expression by sere from patients with active Behçet's disease: moderate correlation with anti-endothelial cell antibodies and serum myeloperoxidase levels. Clin Immunol 91:330–337

    Article  PubMed  Google Scholar 

  142. Trojano M, Paolicelli D (2001) The differential diagnosis of multiple sclerosis: classification and clinical features of relapsing and progressive neurological syndromes. Neurol Sci 22Suppl 2:S98–102

    Article  PubMed  Google Scholar 

  143. Tursen U, Kaya TI, Eskandari G, et al. (2001) Association of factor V Leiden and prothrombin gene mutation with Behcet's disease. Arch Dermatol Res 293:537–539

    PubMed  Google Scholar 

  144. Vaiopoulos G, Sfikakis PP, Hatzinikolaou P (1996) Adamantiades-Behçet's disease in sisters. Clin Rheumatol 15:382–384

    PubMed  Google Scholar 

  145. Verity DH, Vaughan RW, Madanat W, Kondeatis E, Zureikat H, Fayyad F, et al. (1997) Factor V Leiden mutation is associated with ocular involvement in Behçet's disease. Am J Ophthalmol 128:352–356

    Article  Google Scholar 

  146. Verity DH, Marr JE, Ohno S, Wallace GR, Stanford MR (1999) Behcet's disease, the Silk Road and HLA-B*51: historical and geographical perspectives. Tissue Antigens 54:213–220

    Article  PubMed  Google Scholar 

  147. Verity DH, Wallace GR, Vaughan RW, et al. (1999) HLA and tumour necrosis factor (TNF) polymorphisms in ocular Behcet's disease. Tissue Antigens 54:264–272

    Article  PubMed  Google Scholar 

  148. Watanabe T, Shimoji S, Sugiyama Y, Tsukamoto T, Yamamoto T (1995) Pulse-dose cyclophosphamide therapy for steroid-refractory autoimmune neurological diseases. Rinsho Shinkeigaku 35:611–616

    PubMed  Google Scholar 

  149. Wechsler B, Bodaghi B, Huong DL, Fardeau C, Amoura Z, Cassoux N, Piette JC, LeHoang P (2000) Efficacy of interferon alfa-2a in severe and refractory uveitis associated with Behçet's disease. Ocul Immunol Inflamm 8:293–301

    Article  PubMed  Google Scholar 

  150. Wechsler B, Du LT, Kieffer E (1999) Cardiovascular manifestations of Behcet's disease. Ann Med Interne (Paris) 150:542–554

    Google Scholar 

  151. Yamamoto JH, Minami M, Inaba G, Masuda K, Mochizuki M (1990) Cellular autoimmunity to retinal specific antigens in patients with Behçet's disease. Br J Ophthalmol 77:584–589

    Google Scholar 

  152. Yamashita N, Kaneoka H, Kaneke S, Takeno M, Oneda K, Koizumi H, et al. (1997) Role of γδT lymphocytes in the development of Behçet's disease. Clin Exp Immunol 107:241–247

    Article  PubMed  Google Scholar 

  153. Yazici H, Pazarli H, Barnes CG, Tüzün Y, Özyazgan Y, Silman A, Serdaroglu S, Oguz V, Yurdakul S, Lovatt GE, Yazici B, Somani S, Müftüoglu A (1990) A controlled trial of azathioprine in Behçet's syndrome. N Engl J Med 322:281–285

    PubMed  Google Scholar 

  154. Yazici H, Basaran G, Hamuryudan V, et al. (1996) The ten-year mortality in Behcet's syndrome. Br J Rheumatol 35:139–141

    PubMed  Google Scholar 

  155. Yazici H, Ozyagan Y (1999) Medical management of Behçet's syndrome. Dev Ophthalmol 31:118–131

    PubMed  Google Scholar 

  156. Zafirakis P, Foster CS (2002) Adamantiades-Behçet disease. In: Foster CS, Vitale AT (eds) Diagnosis and treatment of uveitis. Saunders, Philadelphia, pp 632–652

    Google Scholar 

  157. Zierhut M, Saal J, Pleyer U, Kötter I, Dürk H, Fierlbeck G (1995) Behçet's disease: epidemiology and eye manifestations in German and Mediterranean patients. Ger J Ophthalmol 4: 246–251

    PubMed  Google Scholar 

  158. Zierhut M, Mizuki N, Ohno S, et al. (2003) Human genome and diseases: review. Immunology and functional genomics of Behcet's diseases. CMSL Cell Mol Life Sci 60:1903–1922

    Article  Google Scholar 

  159. Zouboulis CC, Buttner P, Djawari D, et al. (1993) The HLA pattern in Adamantiades-Behcet's disease in Germany. Association of occurrence, clinical symptoms and follow-up in 39 patients. Hautarzt 44:81–85

    PubMed  Google Scholar 

  160. Zouboulis CC, Djawari D, Kich W (1993) Adamantiades-Behçet's disease in Germany. In: Godeau P, Wechsler B (eds) Behçet's disease. Elsevier Science, New York, pp 193–196

    Google Scholar 

  161. Zouboulis CC, Kötter I, Djawari D, et al. (1997) Epidemiological features of Adamantiades-Behçet's disease in Germany and in Europe. Yonsei Med J 38:411–422

    PubMed  Google Scholar 

  162. Zouboulis CC (1999) Epidemiology of Adamantiades-Behcet's disease. Ann Med Interne (Paris) 150:488–498

    Google Scholar 

  163. Zouboulis CC (2003) Epidemiology of Adamantiades-Behçet's disease. In: Zierhut M, Ohno S (eds) Immunology of Behçet's disease. Swets & Zeitlinger, Nisse, Netherlands, pp 1–16

    Google Scholar 

Download references

Authors
  1. Manfred Zierhut
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nicole Stübiger
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Christoph Deuter
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ina Kötter
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Ophthalmology, Augenklinik Charité, Campus Virchow Klinikum, Augustenburger Platz 1, 13353, Berlin, Germany

    Günther K. Krieglstein MD (Professor) (Professor)

  2. Ophthalmology, Jules Stein Eye Institute, 100 Stein Plaza #2-142, Los Angeles, CA, 90095-7000, USA

    Robert N. Weinreb MD (Professor) (Professor)

  3. Department of Ophthalmology, University of Cologne, Joseph-Stelzmann-Straße 9, 50931, Cologne, Germany

    Uwe Pleyer MD (Professor) (Professor)

  4. Hamilton Glaucoma Center Department of Ophthalmology - 0946, University of California at San Diego, 9500 Gilman Drive, La Jolla, CA, 92093-0946, USA

    Bartly Mondino MD (Professor) (Professor)

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Zierhut, M., Stübiger, N., Deuter, C., Kötter, I. (2005). Behçet's Disease. In: Krieglstein, G.K., Weinreb, R.N., Pleyer, U., Mondino, B. (eds) Uveitis and Immunological Disorders. Essentials in Ophthalmology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-26752-2_12

Download citation

  • DOI: https://doi.org/10.1007/3-540-26752-2_12

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-20045-1

  • Online ISBN: 978-3-540-26752-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation